400
Participants
Start Date
July 31, 2011
Primary Completion Date
December 31, 2026
Study Completion Date
December 31, 2027
Data Collection
Abramson Cancer Center of the University of Pennsylvania, Philadelphia
Abramson Cancer Center at Penn Medicine
OTHER